Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026.
- Largest single sale: $37.8M (245,088 shares) of Neurocrine Biosciences Inc on May 19, 2026. Filing
- Last sale before this period: Aug 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Director | Feb 12, 2004 | Sep 15, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 11, 2026, Neurocrine Biosciences Inc: 14,343 shares awarded; 7,839 shares withheld by the company for taxes. 1 filing: 1
- May 19, 2026, Neurocrine Biosciences Inc: sold 245,088 shares for $37.8M, under a disclosed plan; 205,088 shares acquired by exercising options. 1 filing: 1
- Feb 13, 2026, Neurocrine Biosciences Inc: 10,981 shares vested; 40,305 shares withheld by the company for taxes; 63,724 shares awarded. 1 filing: 1
- Jan 31, 2026, Neurocrine Biosciences Inc: 5,142 shares vested; 2,845 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.